Fabrication of hybrid scaffolds by polymer deposition system and its in-vivo evaluation with a rat tibial defect model

Min Woo Sa, Sung Eun Kim, Young Pil Yun, Hae Ryong Song, Jong Young Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The purpose of this study was to investigate the bone regeneration ability of a polycaprolactone (PCL) tube scaffold fabricated by using a polymer deposition system with G-code and to evaluate the biocompatibility of bone graft material with Bio-C (HA (30%)/TCP (70%)), carboxymethyl cellulose (CMC), and bone morphogenetic protein-2(BMP-2). The fabrication of a rapid prototyping-based PCL tube scaffold requires a combination of several devices, including a heater, pressure dispenser, and motion controller, etc. This system can process polymer with high precision by a 200-μm nozzle. We used scanning electron microscopy to observe the surface of fabricated scaffold. Three groups considered in this study were PCL tube scaffold (Group A), BMP-2(0.1 mg)/Bio-C/CMC/PCL scaffold (Group B), and BMP-2(0.5 mg)/Bio-C/CMC/PCL scaffold (Group C). The functional recovery and bone regeneration potential were estimated by performing an in-vivo animal experiment with a white rat model. Then, the effect of the scaffold on tibial defects in rats was examined by observing an X-ray image at 4 or 8 weeks and by carrying out histological analysis. In this study, scaffolds fabricated by using the PDS (polymer deposition system), had a diameter of 4.0 mm and a height of 8.0 mm. Moreover, we confirmed that group C exhibited better biomedical characteristics for bone formation than the other scaffolds. The evaluation of in-vivo experimental results suggested that the co-fabrication of the PCL tube scaffold with group C resulted in sustained bone regeneration, which in turn improved the biocompatibility of the bone graft material.

Original languageEnglish
Pages (from-to)439-445
Number of pages7
JournalTissue Engineering and Regenerative Medicine
Volume11
Issue number6
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Scaffolds
Rats
Polycaprolactone
Polymers
Bone
Fabrication
Bone Morphogenetic Protein 2
Defects
Carboxymethylcellulose Sodium
Bone Regeneration
Scaffolds (biology)
Cellulose
Proteins
Transplants
Biocompatibility
Bone and Bones
Grafts
Osteogenesis
Electron Scanning Microscopy
Dispensers

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Fabrication of hybrid scaffolds by polymer deposition system and its in-vivo evaluation with a rat tibial defect model. / Sa, Min Woo; Kim, Sung Eun; Yun, Young Pil; Song, Hae Ryong; Kim, Jong Young.

In: Tissue Engineering and Regenerative Medicine, Vol. 11, No. 6, 01.01.2014, p. 439-445.

Research output: Contribution to journalArticle

@article{4d6a251f0e784040b8f2f0acfcbe86db,
title = "Fabrication of hybrid scaffolds by polymer deposition system and its in-vivo evaluation with a rat tibial defect model",
abstract = "The purpose of this study was to investigate the bone regeneration ability of a polycaprolactone (PCL) tube scaffold fabricated by using a polymer deposition system with G-code and to evaluate the biocompatibility of bone graft material with Bio-C (HA (30{\%})/TCP (70{\%})), carboxymethyl cellulose (CMC), and bone morphogenetic protein-2(BMP-2). The fabrication of a rapid prototyping-based PCL tube scaffold requires a combination of several devices, including a heater, pressure dispenser, and motion controller, etc. This system can process polymer with high precision by a 200-μm nozzle. We used scanning electron microscopy to observe the surface of fabricated scaffold. Three groups considered in this study were PCL tube scaffold (Group A), BMP-2(0.1 mg)/Bio-C/CMC/PCL scaffold (Group B), and BMP-2(0.5 mg)/Bio-C/CMC/PCL scaffold (Group C). The functional recovery and bone regeneration potential were estimated by performing an in-vivo animal experiment with a white rat model. Then, the effect of the scaffold on tibial defects in rats was examined by observing an X-ray image at 4 or 8 weeks and by carrying out histological analysis. In this study, scaffolds fabricated by using the PDS (polymer deposition system), had a diameter of 4.0 mm and a height of 8.0 mm. Moreover, we confirmed that group C exhibited better biomedical characteristics for bone formation than the other scaffolds. The evaluation of in-vivo experimental results suggested that the co-fabrication of the PCL tube scaffold with group C resulted in sustained bone regeneration, which in turn improved the biocompatibility of the bone graft material.",
keywords = "Bio-C(composite (HA(30{\%})/β-TCP(70{\%})), Bone morphogenetic protein-2 (BMP-2), Carboxymethyl cellulose (CMC), Polycaprolactone (PCL), Polymer deposition system (PDS), Scaffold",
author = "Sa, {Min Woo} and Kim, {Sung Eun} and Yun, {Young Pil} and Song, {Hae Ryong} and Kim, {Jong Young}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s13770-014-0065-0",
language = "English",
volume = "11",
pages = "439--445",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "6",

}

TY - JOUR

T1 - Fabrication of hybrid scaffolds by polymer deposition system and its in-vivo evaluation with a rat tibial defect model

AU - Sa, Min Woo

AU - Kim, Sung Eun

AU - Yun, Young Pil

AU - Song, Hae Ryong

AU - Kim, Jong Young

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The purpose of this study was to investigate the bone regeneration ability of a polycaprolactone (PCL) tube scaffold fabricated by using a polymer deposition system with G-code and to evaluate the biocompatibility of bone graft material with Bio-C (HA (30%)/TCP (70%)), carboxymethyl cellulose (CMC), and bone morphogenetic protein-2(BMP-2). The fabrication of a rapid prototyping-based PCL tube scaffold requires a combination of several devices, including a heater, pressure dispenser, and motion controller, etc. This system can process polymer with high precision by a 200-μm nozzle. We used scanning electron microscopy to observe the surface of fabricated scaffold. Three groups considered in this study were PCL tube scaffold (Group A), BMP-2(0.1 mg)/Bio-C/CMC/PCL scaffold (Group B), and BMP-2(0.5 mg)/Bio-C/CMC/PCL scaffold (Group C). The functional recovery and bone regeneration potential were estimated by performing an in-vivo animal experiment with a white rat model. Then, the effect of the scaffold on tibial defects in rats was examined by observing an X-ray image at 4 or 8 weeks and by carrying out histological analysis. In this study, scaffolds fabricated by using the PDS (polymer deposition system), had a diameter of 4.0 mm and a height of 8.0 mm. Moreover, we confirmed that group C exhibited better biomedical characteristics for bone formation than the other scaffolds. The evaluation of in-vivo experimental results suggested that the co-fabrication of the PCL tube scaffold with group C resulted in sustained bone regeneration, which in turn improved the biocompatibility of the bone graft material.

AB - The purpose of this study was to investigate the bone regeneration ability of a polycaprolactone (PCL) tube scaffold fabricated by using a polymer deposition system with G-code and to evaluate the biocompatibility of bone graft material with Bio-C (HA (30%)/TCP (70%)), carboxymethyl cellulose (CMC), and bone morphogenetic protein-2(BMP-2). The fabrication of a rapid prototyping-based PCL tube scaffold requires a combination of several devices, including a heater, pressure dispenser, and motion controller, etc. This system can process polymer with high precision by a 200-μm nozzle. We used scanning electron microscopy to observe the surface of fabricated scaffold. Three groups considered in this study were PCL tube scaffold (Group A), BMP-2(0.1 mg)/Bio-C/CMC/PCL scaffold (Group B), and BMP-2(0.5 mg)/Bio-C/CMC/PCL scaffold (Group C). The functional recovery and bone regeneration potential were estimated by performing an in-vivo animal experiment with a white rat model. Then, the effect of the scaffold on tibial defects in rats was examined by observing an X-ray image at 4 or 8 weeks and by carrying out histological analysis. In this study, scaffolds fabricated by using the PDS (polymer deposition system), had a diameter of 4.0 mm and a height of 8.0 mm. Moreover, we confirmed that group C exhibited better biomedical characteristics for bone formation than the other scaffolds. The evaluation of in-vivo experimental results suggested that the co-fabrication of the PCL tube scaffold with group C resulted in sustained bone regeneration, which in turn improved the biocompatibility of the bone graft material.

KW - Bio-C(composite (HA(30%)/β-TCP(70%))

KW - Bone morphogenetic protein-2 (BMP-2)

KW - Carboxymethyl cellulose (CMC)

KW - Polycaprolactone (PCL)

KW - Polymer deposition system (PDS)

KW - Scaffold

UR - http://www.scopus.com/inward/record.url?scp=84916883270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916883270&partnerID=8YFLogxK

U2 - 10.1007/s13770-014-0065-0

DO - 10.1007/s13770-014-0065-0

M3 - Article

AN - SCOPUS:84916883270

VL - 11

SP - 439

EP - 445

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 6

ER -